POCI
Precision Optics Corporation, Inc.
There isn't enough reported data to score POCI yet.
POCI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
POCI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
POCI PE Valuation
POCI has no meaningful PE right now: it lost money over the past year.
POCI Forward outlook
There aren't enough analyst estimates for POCI to show an outlook.
POCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$0.64 | +$0.25 |
| Q4 2025 | -$0.93 | -$0.29 |
| Q3 2025 | -$0.85 | -$0.23 |
| Q2 2025 | -$0.85 | -$0.36 |
| Q1 2025 | -$0.89 | -$0.61 |
| Q4 2024 | -$0.64 | -$0.34 |
| Q3 2024 | -$0.62 | -$0.56 |
| Q2 2024 | -$0.49 | -2550% |
POCI lost $0.64 per share over the past year, a smaller loss than the year before.
POCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +42% |
| Q1 2026 | $8.7M | +108% |
| Q4 2025 | $7.4M | +63% |
| Q3 2025 | $6.7M | +59% |
| Q2 2025 | $6.2M | +31% |
| Q1 2025 | $4.2M | -20% |
| Q4 2024 | $4.5M | -6.2% |
| Q3 2024 | $4.2M | -2.9% |
POCI's revenue has grown year over year for five quarters in a row: $9M last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | +21 points |
| Q1 2026 | -0.7% | +48 points |
| Q4 2025 | -24% | -3.5 points |
| Q3 2025 | -24% | +5.8 points |
| Q2 2025 | -22% | +6.8 points |
| Q1 2025 | -49% | -44 points |
| Q4 2024 | -20% | -5.5 points |
| Q3 2024 | -30% | -20 points |
POCI's operating margin was −1.2% last quarter, up 21 points from the same quarter a year ago.
POCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$723.3K | +$1.3M |
| Q4 2025 | -$256.1K | +$560.6K |
| Q3 2025 | $78.2K | +$421.2K |
| Q2 2025 | -$615.5K | +$372.2K |
| Q1 2025 | -$2M | -$1.7M |
| Q4 2024 | -$816.6K | -$575.3K |
| Q3 2024 | -$343K | +$1.1M |
| Q2 2024 | -$987.6K | -$395.8K |
POCI has burned cash in most quarters: −$2M over the past year, against −$4M the year before.
POCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +79.5K shares |
| 1 year | +13% | +877K shares |
| 3 years | +38% | +2.2M shares |
| 5 years | +66% | +3.1M shares |
| Available history | +82% | +3.5M shares |
POCI has 8M diluted shares, up 13% from a year ago.
POCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 4.6x | High |
POCI's net debt is about 4.6 years of its operating earnings (EBITDA).
POCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 69.4 | Neutral |
POCI's weekly RSI is 59 (neutral) and its Stochastic is 69 (neutral).
POCI PE vs Healthcare Sector
| Metric | POCI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
POCI has no meaningful PE right now: it lost money over the past year.
POCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.61 | 8.5% above |
| 20 week MA | $4.53 | 10% above |
| 50 week MA | $4.60 | 8.7% above |
| 100 week MA | $4.59 | 8.9% above |
| 200 week MA | $5.26 | 4.9% below |
POCI has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 4.9% below its 200-week average.
POCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.40 | $4.20 | -22% |
| 2021 | $4.20 | $7.20 | +71% |
| 2022 | $7.20 | $5.55 | -23% |
| 2023 | $5.55 | $6.02 | +8.5% |
| 2024 | $6.02 | $5.01 | -17% |
| 2025 | $5.01 | $4.21 | -16% |
| 2026 YTD | $4.21 | $5.00 | +19% |
POCI has finished lower in four of the last six years. It's up 19% so far in 2026.